Jeffrey A. Fielkow
Known title: DirectorCIK: 0001968494
Jeffrey A. Fielkow's purchase track record
How the stock did after each of Jeffrey A. Fielkow's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since May 4, 2023
Stock higher 6 months later
80%
3 months: 100%
Median 6-month return
+22.1%
3 months: +14.9%
Beat the S&P 500
60%
median +10.2% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/11/2025 | TRS | $63K | +14.9% | +29.9% | +8.1% |
| 5/19/2025 | TRS | $12K | +42.8% | +22.1% | +11.9% |
| 2/28/2025 | TRS | $52K | +28.9% | +89.3% | +8.5% |
| 3/4/2024 | TRS | $24K | +14.2% | +7.4% | +7.8% |
| 5/4/2023 | TRS | $25K | +3.3% | -3.5% | +6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TRS | ▲ Buy | Grant | 2,853 | $0 | 3/14/2026 | View on chart |
| TRS | ▲ Buy | Open Market | 2,000 | $63K | 11/11/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 500 | $12K | 5/19/2025 | View on chart |
| TRS | ▲ Buy | Grant | 4,140 | $0 | 3/14/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 2,500 | $52K | 2/28/2025 | View on chart |
| TRS | ▲ Buy | Grant | 4,068 | $0 | 3/14/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 1,000 | $24K | 3/4/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 1,000 | $25K | 5/4/2023 | View on chart |
| TRS | ▲ Buy | Grant | 3,445 | $0 | 3/11/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
TriMas Sets Q3 2026 Earnings Call Date
TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.
TriMas Sets Q3 2026 Earnings Call Date. TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.